CORRECT: Amgen Anemia Drugs Are Aranesp, Epogen
(An item at 4:23 p.m. EST Friday incorrectly identified Amgen's anemia franchise.)
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=7%2FK5XsmKTKlbfkvDKSg7eA%3D%3D. You can use this link on the day this article is published and the following day.
Publié le 19 Décembre 2008 Copyright © 2008 Dowjones
Partager sur:
Actualités
Suite »
- 04/11 : MARKET SNAPSHOT: U.S. Stocks Open Higher; Jobs Outlook… (DJ)
- 03/11 : Merck/Schering Cholesterol Drugs At Another Crossroads (DJ)
- 02/11 : FDA Says No To Application For Potential Lipitor/Zetia… (DJ)
- 29/10 : Priceline.com To Replace Schering-Plough In S&P 500… (DJ)
- 29/10 : UPDATE: US FTC Clears Merck-Schering Deal, With Conditions (DJ)
Actualités sectorielles
Suite »
- 20/11 : CDC: Sees Slight Decline In H1N1 Influenza Illnesses (DJ)
- 20/11 : NicOx: lourd repli, un analyste dégrade. (CF)
- 20/11 : ECHO BOURSE: NicOx déclassé de conserver… (DJ)
- 19/11 : BioAlliance: distingué pour sa croissance par Deloitte. (CF)
- 19/11 : Cellectis: maintien d'un brevet européen par l'OEB. (CF)